Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
754.40
Change Change %
2.50 0.33%

Updated:17 Aug, 2018, 15:51 PM IST

BSE
752.50
Change Change %
0.35 0.05%

Updated:17 Aug, 2018, 16:01 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

749.00 769.90

52 Wk Range

695.00 1050.00
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

750.00776.00

52 Wk Range

695.45 1061.95

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below
 

's Latest Research Report

Brokerage/Analyst Report Date Call Price@Call Target Current Status Report
Nirmal Bang
-
28-02-2017 Buy 809.65 725.00 Target Hit Details
Religare
-
16-02-2017 Sell 771.20 655.00 Closed Details
Axis Capital
-
07-12-2016 Buy 598.40 725.00 Target Hit Details
Religare
-
17-11-2015 Buy 2445.50 3005.00 Closed Details

Natco Pharma's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 13,918.15
Earning Per Share (EPS TTM) (₹) 43.58
Price To Earnings (P/E) Ratio 17.31
Book Value Per Share (₹) 96.52
Price To Books (P/B) Ratio 7.82
EBIT Margin (%) 32.53
PAT Margin (%) 24.71
ROCE (%) 38.71
PAT Growth (%) 180.34
Total Debt to Equity (D/E) Ratio 0.13

More from Key Fundamentals »

Natco Pharma's Financial Summary

Parameter MAR'17
(₹ Cr.)
MAR'16
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 34.90 34.80 0.29%
Total Non-Current Liabilities 37.70 27.90 35.13%
Total Current Liabilities 609.70 478.50 27.42%
Total Liabilities 2,347.10 1,842.70 27.37%
Total Non-Current Assets 1,312.00 1,051.80 24.74%
Currents Investments 8.90 22.10 -59.73%
Cash and Bank 25.10 40.20 -37.56%
Total Current Assets Excluding Current Investments 1,026.20 768.80 33.48%
Total Assets 2,347.10 1,842.70 27.37%
Profit and Loss:
Gross Sales 2,002.80 1,059.20 89.09%
Net Sales 1,958.00 1,021.40 91.70%
PBIDT (Excl OI) 692.00 280.70 146.53%
PAT 494.80 176.50 180.34%

More from Financial Summary »

Natco Pharma's Shareholding Pattern

..

Post your comments about Natco Pharma

Top